Article
Biomarker-based outcome prediction in prostate adenocarcinoma depends on the <i>TMPRSS2-ERG</i> status
2019-02-10
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Prostate adenocarcinoma (PCa) with/without the TMPRSS2-ERG (T2E)-fusion represent distinct molecular subtypes. <h4>Objective</h4> To investigate gene-signatures associated with metastasis in T2E-positive and -negative PCa, and to identify and validate subtype-specific prognostic biomarkers. <h4>Design, setting and participants</h4> Gene expression and clinicopathological...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 59cc91ab-cc4c-5f56-80d7-eb99e074e823
- DOI
- 10.1101/546200
